CBD, or cannabidiol, has recently been receiving a lot of attention in the medical community, and for good reasons. There are numerous studies published that show the tremendous medical value CBD contains, unfortunately very few studies have been performed on humans, but this is about to change.
When it comes to CBD, numerous studies show CBD positively effects neurological diseases, inflammatory illness and cancer. CBD is best for therapeutic treatment of neurodegenerative illness such as pediatric epilepsy. CBD can help prevent nerve damage due to alcohol poisoning. CBD appears to calm autonomic responses to stress like rapid heartbeat by engaging receptors that select serotonin to achieve a calming effect.
Cannabidiol’s therapeutic potential is based on its antipsychotic anxiolytic and antidepressant effects. CBD is able to reduce symptoms of acute paranoid schizophrenia as well as pharmaceuticals like amisulpride which, unlike CBD has, significant side effects.
CBD has been shown to have clear and measurable therapeutic impact on inflammatory and anti-inflammatory regulation mechanisms such as inflammatory bowel disease, arthritis, periodontitis and atherosclerosis.
With regards to cancer, CBD is able to produce significant anti-cancer activity both in vitro and in vivo. Further, CBD has been shown to selectively produce oxidative stress in cancer cells,* thus producing apoptosis (cancer cell suicide) without impacting normal cells.
These are just some of the many findings we are learning about how CBD can benefit our communities.